Duno M - Search Results

1

BAG3 myopathy is not always associated with cardiomyopathy.

Andersen AG, Fornander F, Schrøder HD, Krag T, Straub V, Duno M, Vissing J. Andersen AG, et al. Among authors: duno m. Neuromuscul Disord. 2018 Sep;28(9):798-801. doi: 10.1016/j.nmd.2018.06.019. Epub 2018 Jul 5. Neuromuscul Disord. 2018. PMID: 30061062

2

Multiple mtDNA deletions with features of MNGIE.

Vissing J, Ravn K, Danielsen ER, Dunø M, Wibrand F, Wevers RA, Schwartz M. Vissing J, et al. Among authors: duno m. Neurology. 2002 Sep 24;59(6):926-9. doi: 10.1212/wnl.59.6.926. Neurology. 2002. PMID: 12297582

3

Decrement of compound muscle action potential is related to mutation type in myotonia congenita.

Colding-Jørgensen E, DunØ M, Schwartz M, Vissing J. Colding-Jørgensen E, et al. Among authors: duno m. Muscle Nerve. 2003 Apr;27(4):449-55. doi: 10.1002/mus.10347. Muscle Nerve. 2003. PMID: 12661046

4

Characterization of two new dominant ClC-1 channel mutations associated with myotonia.

Grunnet M, Jespersen T, Colding-Jørgensen E, Schwartz M, Klaerke DA, Vissing J, Olesen SP, Dunø M. Grunnet M, et al. Among authors: duno m. Muscle Nerve. 2003 Dec;28(6):722-32. doi: 10.1002/mus.10501. Muscle Nerve. 2003. PMID: 14639587 Clinical Trial.

5

Difference in allelic expression of the CLCN1 gene and the possible influence on the myotonia congenita phenotype.

Dunø M, Colding-Jørgensen E, Grunnet M, Jespersen T, Vissing J, Schwartz M. Dunø M, et al. Eur J Hum Genet. 2004 Sep;12(9):738-43. doi: 10.1038/sj.ejhg.5201218. Eur J Hum Genet. 2004. PMID: 15162127

6

Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations.

Ørngreen MC, Dunø M, Ejstrup R, Christensen E, Schwartz M, Sacchetti M, Vissing J. Ørngreen MC, et al. Among authors: duno m. Ann Neurol. 2005 Jan;57(1):60-6. doi: 10.1002/ana.20320. Ann Neurol. 2005. PMID: 15622536

7

Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy.

Jeppesen TD, Schwartz M, Olsen DB, Wibrand F, Krag T, Dunø M, Hauerslev S, Vissing J. Jeppesen TD, et al. Among authors: duno m. Brain. 2006 Dec;129(Pt 12):3402-12. doi: 10.1093/brain/awl149. Epub 2006 Jun 30. Brain. 2006. PMID: 16815877

8

Autosomal dominant monosymptomatic myotonia permanens.

Colding-Jørgensen E, Duno M, Vissing J. Colding-Jørgensen E, et al. Among authors: duno m. Neurology. 2006 Jul 11;67(1):153-5. doi: 10.1212/01.wnl.0000223838.88872.da. Neurology. 2006. PMID: 16832098

9

Do carriers of PYGM mutations have symptoms of McArdle disease?

Andersen ST, Dunø M, Schwartz M, Vissing J. Andersen ST, et al. Among authors: duno m. Neurology. 2006 Aug 22;67(4):716-8. doi: 10.1212/01.wnl.0000230154.79933.d7. Neurology. 2006. PMID: 16924035 Clinical Trial.

10

Deletion of exon 16 of the dystrophin gene is not associated with disease.

Schwartz M, Dunø M, Palle AL, Krag T, Vissing J. Schwartz M, et al. Among authors: duno m. Hum Mutat. 2007 Feb;28(2):205. doi: 10.1002/humu.9477. Hum Mutat. 2007. PMID: 17226814

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

197 results

Search Page